EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy

Jacob Kaiserman iD, Bethany A O'Hara, Sheila A Haley, Walter J Atwood iD

International Journal of Molecular Sciences · 11.05.2023 · 24 (10) · 8580

DOI: 10.3390/ijms24108580 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.05.2023. Verfasst von Jacob Kaiserman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Leukoencephalopathy, Progressive Multifocal, JC Virus, Polyomavirus Infections. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disease and Stroke, Brown University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused by infection with JC Polyomavirus (JCPyV). Despite the identification of the disease and isolation of the causative pathogen over fifty years ago, no antiviral treatments or prophylactic vaccines exist. Disease onset is usually associated with immunosuppression, and current treatment guidelines are limited to restoring immune function. This review summarizes the drugs and small molecules that have been shown to inhibit JCPyV infection and spread. Paying attention to historical developments in the field, we discuss key steps of the virus lifecycle and antivirals known to inhibit each event. We review current obstacles in PML drug discovery, including the difficulties associated with compound penetrance into the central nervous system. We also summarize recent findings in our laboratory regarding the potent anti-JCPyV activity of a novel compound that antagonizes the virus-induced signaling events necessary to establish a productive infection. Understanding the current panel of antiviral compounds will help center the field for future drug discovery efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukoencephalopathy, Progressive MultifocalJC VirusPolyomavirus InfectionsHumansSignal Transduction

Stichwörter der Autor:innen

GW-5074PMLantiviraldrug discoverypolyomavirusprogressive multilocal encephalopathysignaling inhibitor

Autor:innen und Institutionen

  • Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.

ORCID-Profile: Jacob Kaiserman, Walter J Atwood

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disease and Stroke
  • Brown University

Zitieren

APA

Kaiserman, J., O'Hara, B. A., Haley, S. A., & Atwood, W. J. (2023). An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy. International Journal of Molecular Sciences, 24(10), 8580. https://doi.org/10.3390/ijms24108580

Vancouver

Kaiserman J, O'Hara BA, Haley SA, Atwood WJ. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy. International Journal of Molecular Sciences. 2023;24(10):8580. doi:10.3390/ijms24108580

BibTeX
@article{Kaiserman2023,
  author = {Kaiserman, Jacob and O'Hara, Bethany A and Haley, Sheila A and Atwood, Walter J},
  title = {An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {8580},
  doi = {10.3390/ijms24108580}
}
Kostenlos starten →